FDA found undeclared tadalafil, the active ingredient in Cialis, in MKS Enterprise's Vital Honey and cited unapproved drug claims.
What happened
FDA bought a sample of Dose Vital Royal Honey VIP Honey from the company's website and reviewed the website in June 2022. Laboratory testing found undeclared tadalafil, the active ingredient in the prescription erectile dysfunction drug Cialis. The website also claimed the honey could prevent or treat arthritis, multiple sclerosis, heart ailments, liver disease, and other conditions.
What FDA found
The honey contains undeclared tadalafil, an approved prescription drug, so it is a food with an added drug and cannot be introduced into interstate commerce.
FD&C Act section 301(ll) [21 U.S.C. 331(ll)]Website claims that the honey treats diseases make it a new drug, but FDA has not approved it for those uses.
FD&C Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]The product is misbranded because it lacks adequate directions for a layperson to use it safely for its claimed purposes.
FD&C Act sections 502(f)(1) and 301(a) [21 U.S.C. 352(f)(1), 331(a)]
What FDA wants
FDA tells the company to notify it in writing within 15 working days of the steps taken to correct the violations and prevent recurrence, with supporting documents, or explain why it cannot complete them and when it will.
Who should pay attention
- retailers and online marketplaces selling honey supplements
- brands that buy or distribute Vital Honey
- consumers taking nitrates or heart medications
This is a summary. Read the original letter on fda.gov.